IO Biotech Files 8-K: Corporate Updates
Ticker: IOBT · Form: 8-K · Filed: Jun 4, 2025 · CIK: 1865494
| Field | Detail |
|---|---|
| Company | Io Biotech, Inc. (IOBT) |
| Form Type | 8-K |
| Filed Date | Jun 4, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, 8-K, company-update
TL;DR
IO Biotech filed an 8-K on June 4th, updating corporate info and financials.
AI Summary
IO Biotech, Inc. filed an 8-K on June 4, 2025, reporting other events and financial statements. The filing details the company's principal executive offices located at Ole Maaløes Vej 3, DK-2200 Copenhagen N, Denmark, and its telephone number +45 7070 2980. The report covers events up to June 3, 2025.
Why It Matters
This 8-K filing provides essential corporate information and updates for IO Biotech, Inc., which is relevant for investors and stakeholders tracking the company's operational status.
Risk Assessment
Risk Level: low — This filing is primarily administrative and does not contain significant financial or operational news that would immediately impact risk.
Key Players & Entities
- IO Biotech, Inc. (company) — Registrant
- June 3, 2025 (date) — Earliest event reported
- June 4, 2025 (date) — Date of report
- Ole Maaløes Vej 3, DK-2200 Copenhagen N, Denmark (location) — Principal executive offices
- +45 7070 2980 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for IO Biotech, Inc.?
The primary purpose is to report 'Other Events' and 'Financial Statements and Exhibits' as of June 3, 2025.
When was this 8-K report filed with the SEC?
The report was filed on June 4, 2025.
Where are IO Biotech, Inc.'s principal executive offices located?
The principal executive offices are located at Ole Maaløes Vej 3, DK-2200 Copenhagen N, Denmark.
What is the telephone number provided for IO Biotech, Inc.?
The telephone number provided is +45 7070 2980.
What is the Commission File Number for IO Biotech, Inc.?
The Commission File Number for IO Biotech, Inc. is 001-41008.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 4, 2025 regarding IO Biotech, Inc. (IOBT).